Jacobs Levy Equity Management, Inc Soleno Therapeutics Inc Transaction History

Jacobs Levy Equity Management, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$0.97 - $1.32 $26,384 - $35,905	-27,201 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.24 - $3.3 $56,906 - $151,443	-45,892 Reduced 62.79%	27,201 $34,000
Q4 2020 Feb 16, 2021	BUY	$1.61 - $2.23 $117,679 - $162,997	73,093 New	73,093 $141,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $362M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.